![](/img/cover-not-exists.png)
Melphalan 180mg/m2 Can Be Safely Administered as Conditioning Regimen Prior to an Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Creatinine Clearance ≤60ml/min/1.73 m2 with Use of Palifermin for Cytoprotection: Results of a Phase I Trial
M.H. Abidi, R. Agarwal, N. Tageja, L. Ayash, M. Ventimiglia, A. Deol, Z. Al-Kadhimi, L. Lum, V. Ratanatharathorn, J. Abrams, J.P. UbertiVolume:
18
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2011.12.142
File:
PDF, 84 KB
english, 2012